Clinical Communications
Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects

https://doi.org/10.1016/j.jaip.2022.02.030Get rights and content

Cited by (0)

Conflicts of interest: The authors declare that they have no relevant conflicts of interest.

∗

D.B. Lewis and M. Pham contributed equally to this work.

View Abstract
© 2022 American Academy of Allergy, Asthma & Immunology